Start with plasma.
Generate reactive species through atmospheric plasma technology.
Let’s connect ↗
BIOMATERIALS. REIMAGINED.
Born from lightning. Built to heal.
Discover the potential of plasma-activated hydrogels.
What if infection control and tissue repair were developed together?
That question drives Gelion Care. We bring plasma physics and biomaterials together to investigate a new generation of active hydrogels for wound care.
See where we’re focused ↗
Our platform combines the reactive chemistry of plasma with the versatility of hydrogels. We’re exploring how these materials can deliver active species locally.
Nitric oxide is one molecule at the heart of this ambition — a small part of biology with exciting research potential.
Generate reactive species through atmospheric plasma technology.
Bring active chemistry into a hydrogel designed for local application.
Study release, antimicrobial activity and compatibility with healing tissue.
Our platform is in development. Safety and clinical effectiveness remain to be established.

INSPIRED BY ENERGY. DRIVEN BY PURPOSE.
Turning a remarkable state of matter
into a new direction for biomaterials.
We’re exploring where our platform could make a meaningful difference — starting with the need to heal.
Investigating new approaches to infection control while considering the needs of fragile, healing tissue.
Exploring the potential of active-species delivery for wounds that struggle to heal, including diabetic foot ulcers and other hard-to-heal wounds.
Looking beyond wounds to understand where the hydrogel platform could support future skin applications.

Bringing different disciplines together.
Working toward a shared ambition.
CEO
CTO
↗Scientific Advisor
↗Business Advisor
SUPPORTED BY
Updates from Gelion Care.
All news ↗NWO Demonstrator supports researchers in translating promising research results into a working demonstrator or Minimum Viable Product (MVP) with clear market potential. Funding can cover technical development, validation, and knowledge-utilisation activities needed to prepare the technology for transfer to an external party or for commercialisation through a spin-off/company.
Read update ↗